These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16260383)

  • 1. The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.
    Navia BA; Rostasy K
    Neurotox Res; 2005 Oct; 8(1-2):3-24. PubMed ID: 16260383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
    Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
    J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective strategies for HIV-1 associated dementia.
    Dou H; Kingsley JD; Mosley RL; Gelbard HA; Gendelman HE
    Neurotox Res; 2004; 6(7-8):503-21. PubMed ID: 15639783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
    Xia C; Luo D; Yu X; Jiang S; Liu S
    Microbes Infect; 2011 May; 13(5):419-25. PubMed ID: 21262373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
    Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B;
    J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAART & the molecular biology of AIDS dementia complex.
    Saksena NK; Smit TK
    Indian J Med Res; 2005 Apr; 121(4):256-69. PubMed ID: 15817943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.
    Ryan LA; Cotter RL; Zink WE; Gendelman HE; Zheng J
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):137-50. PubMed ID: 11995633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV dementia: an evolving disease.
    McArthur JC
    J Neuroimmunol; 2004 Dec; 157(1-2):3-10. PubMed ID: 15579274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
    Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
    Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementia complex due to HIV disease and aging].
    Moulignier A
    Psychol Neuropsychiatr Vieil; 2007 Sep; 5(3):193-207. PubMed ID: 17872328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
    Power C; Gill MJ; Johnson RT
    Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.
    Chang L; Ernst T; Witt MD; Ames N; Walot I; Jovicich J; DeSilva M; Trivedi N; Speck O; Miller EN
    Antivir Ther; 2003 Feb; 8(1):17-26. PubMed ID: 12713060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
    Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
    AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients.
    Power C; McArthur JC; Nath A; Wehrly K; Mayne M; Nishio J; Langelier T; Johnson RT; Chesebro B
    J Virol; 1998 Nov; 72(11):9045-53. PubMed ID: 9765449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 encephalopathy in children.
    Gelbard HA; Epstein LG
    Curr Opin Pediatr; 1995 Dec; 7(6):655-62. PubMed ID: 8776015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of human immunodeficiency virus-induced neurological disease.
    Albright AV; Soldan SS; González-Scarano F
    J Neurovirol; 2003 Apr; 9(2):222-7. PubMed ID: 12707852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
    Lipton SA
    Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.